Francisco Vasques-Nóvoa
Universidade do Porto
H-index: 13
Europe-Portugal
Top articles of Francisco Vasques-Nóvoa
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: a post hoc analysis of the FIGHT trial
Diabetes, Obesity and Metabolism
2023/1
Fenofibrate and heart failure outcomes in patients with type 2 diabetes: analysis from ACCORD
Diabetes Care
2022/7/7
João Pedro Ferreira
H-Index: 8
Francisco Vasques-Nóvoa
H-Index: 8
Abhinav Sharma
H-Index: 6
Adelino Leite-Moreira
H-Index: 43
New peptide functionalized nanostructured lipid carriers with CNS drugs and evaluation anti-proliferative activity
International Journal of Molecular Sciences
2022/6/26
In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan
Nature Aging
2022/5
Rui Ribeiro
H-Index: 25
Francisco Vasques-Nóvoa
H-Index: 8
Myocardial oedema: pathophysiological basis and implications for the failing heart
2022/4
Interleukin-6, infection and cardiovascular outcomes in acute heart failure: Findings from the EDIFICA registry
Cytokine
2022/12/1
Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort
International Journal of Cardiology
2022/10/15
Francisco Vasques-Nóvoa
H-Index: 8
Guilherme Ferreira
H-Index: 0
Jorge Almeida
H-Index: 4
João Pedro Ferreira
H-Index: 8
Adelino Leite-Moreira
H-Index: 43
Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes
European Journal of Heart Failure
2022/10
Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Critical Care
2022/9/18
Filippo Annoni
H-Index: 7
Francisco Vasques-Nóvoa
H-Index: 8
Jean-Louis Vincent
H-Index: 114
Antoine Herpain
H-Index: 9
Effect of glucagon‐like peptide‐1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: a meta‐analysis of placebo‐controlled randomized trials
Diabetes, Obesity and Metabolism
2022/8
Chronic sildenafil therapy in the ZSF1 obese rat model of metabolic syndrome and heart failure with preserved ejection fraction
2021/11
Rui Cerqueira
H-Index: 21
Francisco Vasques-Nóvoa
H-Index: 8
Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities
Biotechnology and Bioengineering
2021/8
Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
BMJ Open Diabetes Research and Care
2021/7/1
Sodium-glucose co-transporter inhibitors in insulin-treated diabetes: a meta-analysis
European Journal of Endocrinology
2021/6
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Science translational medicine
2021/2/10
Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and …
Frontiers in Cell and Developmental Biology
2021/2/4
Mitochondrial reversible changes determine diastolic function adaptations during myocardial (reverse) remodeling
Circulation: Heart Failure
2020/11
Alexandre Gonçalves
H-Index: 19
Francisco Vasques-Nóvoa
H-Index: 8
José Magalhães
H-Index: 1
Adelino Leite-Moreira
H-Index: 43
Exercise preconditioning prevents left ventricular dysfunction and remodeling in monocrotaline-induced pulmonary hypertension
Porto Biomedical Journal
2020/9/1
Francisco Vasques-Nóvoa
H-Index: 8
Adelino Leite-Moreira
H-Index: 43
Myocardial edema: an overlooked mechanism of septic cardiomyopathy?
Shock
2020/5/1
Francisco Vasques-Nóvoa
H-Index: 8
Myocardial edema and remodeling: a link between acute myocarditis and septic cardiomyopathy?
Journal of the American College of Cardiology
2020/3/31
Francisco Vasques-Nóvoa
H-Index: 8
